BIOPHTA
Company

Last deal

$7.1M
Local Amount - EUR 6.5M

Amount

Seed

Stage

03.06.2024

Date

1

all rounds

$7.1M

Total amount

General

About Company
BIOPHTA has pioneered a novel approach to eye care by creating a cutting-edge pharmaceutical platform that enables continuous drug delivery.

Also Known As

BIOPHTA (BIOADHESIVE OPHTALMICS)

founded date

2020

Number of employees

Company Type

For Profit

Last funding type

Seed

IPO status

Private

Description

BIOPHTA has pioneered a new approach to eye care by creating a cutting-edge pharmaceutical platform that enables continuous drug delivery. Their non-invasive topical ocular inserts represent a significant advancement in the treatment of many ophthalmic disorders, providing superior long-term disease management.
Contacts

Social url